NIH Study Sections Explained: How Peer Review Really Works

What Is a Study Section?

A study section — formally called a Scientific Review Group (SRG) — is a panel of external scientists convened by NIH to evaluate the scientific and technical merit of grant applications. Study sections are the first level of NIH's dual review system. Their job is to assess quality and assign scores; they do not make funding decisions. That responsibility falls to the Advisory Councils of the individual institutes, which consider the study section's scores alongside programmatic priorities and available budget.

The concept is straightforward: scientists who are experts in a field evaluate proposals from their peers. This system, which has been the backbone of NIH funding since 1946, is designed to ensure that taxpayer dollars support the most meritorious and impactful research. Approximately 18,000 scientists serve on NIH review panels each year, most as volunteers who view service as a professional obligation and an opportunity to shape the direction of their field.

Understanding how study sections operate is not merely academic. The way you write your application, structure your aims, and present your qualifications should be directly informed by what reviewers are looking for and how the review process works. Applicants who understand the review process write fundamentally different — and more competitive — applications than those who treat it as a black box.

How Study Sections Are Organized

The Center for Scientific Review (CSR) organizes and manages the peer review of approximately 75% of all NIH grant applications. CSR maintains more than 175 standing study sections, grouped into Integrated Review Groups (IRGs) by broad scientific discipline. Each IRG contains multiple study sections with more specific focus areas.

Standing Study Sections

Standing study sections have a defined membership that serves for terms of up to 6 years, with staggered appointments so that roughly one-third of the membership rotates each year. Each standing panel has 15-30 members, though not all attend every meeting. The Scientific Review Officer (SRO, formerly called the Scientific Review Administrator or SRA) is the NIH staff member who manages the study section — recruiting members, assigning applications to reviewers, running the meeting, and producing summary statements.

Standing study sections meet three times per year, corresponding to the three standard NIH receipt date cycles. Membership typically includes a mix of senior and mid-career scientists representing the breadth of scientific topics the panel covers. The SRO aims to balance expertise so that every application can be reviewed by at least three members with relevant knowledge.

Special Emphasis Panels (SEPs)

When applications do not fit well into any standing study section, or when an FOA (particularly an RFA or PAR) requires specialized review, CSR or an individual institute convenes a Special Emphasis Panel. SEPs are assembled ad hoc for a specific set of applications, and their membership is recruited specifically for the scientific expertise needed. SEPs may also be used to handle conflict-of-interest situations when a standing study section member has a conflict with a particular application.

Key Players in the Review Process

• Scientific Review Officer (SRO): NIH staff member who manages the study section. Assigns applications to reviewers, ensures review quality, and produces summary statements. Not a voting member.
• Chairperson: An experienced study section member who presides over the meeting, moderates discussion, ensures fairness, and manages time. Serves a 2-year term.
• Permanent Members: Scientists appointed to 4-6 year terms who provide continuity and calibration across review cycles.
• Temporary Members (Ad Hoc Reviewers): Scientists recruited for a single meeting cycle to provide expertise not represented among permanent members.
• Designated Federal Official: NIH staff member (often the SRO) responsible for ensuring the review complies with federal advisory committee regulations.

The Review Criteria: What Reviewers Score

NIH peer review evaluates applications against five scored review criteria, plus several additional unscored factors. Understanding exactly what each criterion means — and how reviewers interpret it in practice — is essential for writing a competitive application.

1. Significance

Does the project address an important problem or critical barrier to progress in the field? If the aims are achieved, how will scientific knowledge, technical capability, or clinical practice be improved? How will successful completion change the concepts, methods, technologies, treatments, services, or preventive interventions that drive the field?

What reviewers look for: A clear articulation of the knowledge gap, evidence that the gap matters (not just that it exists), and a convincing argument that filling this gap will have meaningful downstream effects. The strongest applications connect their work to health outcomes or foundational scientific understanding. Weak significance sections describe what the project will do without explaining why it matters.

2. Investigator(s)

Are the PIs, collaborators, and other researchers well suited to the project? Do they have appropriate experience, training, and a track record of accomplishment? If the project is collaborative, do the investigators have complementary expertise and a leadership approach appropriate for the work?

What reviewers look for: Evidence that the team has the specific technical skills the project requires, demonstrated through publications, prior grants, and the biosketch narratives. For new investigators, reviewers look for strong mentoring relationships, institutional support, and evidence of emerging independence. For MPI applications, reviewers assess whether the leadership plan is realistic and whether the collaboration adds genuine value.

3. Innovation

Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel concepts, approaches, methodologies, or technologies? Are the concepts, approaches, or methods novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of existing approaches proposed?

What reviewers look for: Innovation does not require inventing entirely new methods. Applying existing tools in novel combinations, adapting methods from one field to another, or asking a fundamentally new question all count. Reviewers become skeptical when applicants claim everything is novel — they want honest differentiation between what is truly new and what builds on existing work. The strongest Innovation sections clearly state what has been done before and then explain specifically how this project goes beyond.

4. Approach

Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims? Have the investigators presented strategies to ensure a robust and unbiased approach, as appropriate for the work proposed? Are potential problems, alternative strategies, and benchmarks for success presented?

What reviewers look for: This is typically the most heavily weighted criterion. Reviewers want to see a detailed, logical experimental plan with appropriate controls, statistical considerations, and sample sizes. They expect you to anticipate what could go wrong and have contingency plans. Preliminary data is evaluated here — it should demonstrate feasibility, not just show that you can run assays. Rigor and reproducibility elements (sex as a biological variable, authentication of key resources, blinding, randomization) are assessed under Approach. A weak Approach score alone can sink an otherwise strong application.

5. Environment

Will the scientific environment contribute to the probability of success? Are the institutional support, equipment, and other physical resources adequate? Is there evidence of institutional commitment?

What reviewers look for: Access to necessary equipment, core facilities, patient populations (for clinical research), and computational resources. For new investigators, institutional start-up packages, protected research time, and mentoring committees signal that the institution is invested in the PI's success. Environment is typically the least differentiating criterion — most applications from established research universities score well — but it can hurt you if specific resources needed for the project are clearly absent.

Additional Review Considerations (Not Scored Individually)

Reviewers also evaluate protections for human subjects, vertebrate animals, biohazards, data management and sharing plans, and budget appropriateness. While these do not receive individual numerical scores, serious concerns in any of these areas can be flagged as conditions of award or, in extreme cases, can affect the Overall Impact score. A budget that reviewers consider excessive for the proposed work will be noted and may be reduced during the funding negotiation.

How Scoring Works

The NIH scoring system uses a 1-9 scale for both individual criterion scores and the Overall Impact score. Understanding the mechanics of this system helps you interpret your summary statement and calibrate your expectations.

The 1-9 Scoring Scale

Score	Descriptor	Meaning
1	Exceptional	Exceptionally strong with essentially no weaknesses
2	Outstanding	Extremely strong with negligible weaknesses
3	Excellent	Very strong with only some minor weaknesses
4	Very Good	Strong but with numerous minor weaknesses
5	Good	Strong but with at least one moderate weakness
6	Satisfactory	Some strengths but also some moderate weaknesses
7	Fair	Some strengths but with at least one major weakness
8	Marginal	A few strengths and numerous significant weaknesses
9	Poor	Very few strengths and numerous major weaknesses

From Individual Scores to Final Impact Score

After the study section discussion, all eligible members (those without conflicts of interest for that application) submit their Overall Impact score. These individual scores are averaged and multiplied by 10 to produce the final impact score, which ranges from 10 (best) to 90 (worst). For example, if the average Overall Impact score from the panel is 2.5, the final impact score is 25.

Percentile Ranking

NIH converts the impact score to a percentile by comparing it against all applications reviewed by that study section over the preceding three review rounds. A percentile of 10 means the application scored better than 90% of all applications reviewed by that panel. Percentiles are the primary metric institutes use for funding decisions because they normalize for differences in scoring stringency across study sections. Some panels score more generously than others, and percentiles correct for this.

Not all applications receive a percentile. Only applications that are discussed (not triaged) and that were submitted through certain FOA types receive percentile rankings. Applications reviewed by SEPs for specific RFAs may receive impact scores but not percentiles, because the comparison pool is too small.

The Role of Assigned Reviewers

Each application is assigned to three reviewers by the SRO: a primary reviewer, a secondary reviewer, and a tertiary reviewer (also called a reader in some panels). These three individuals carry the greatest influence over the application's fate, though all panel members ultimately vote.

Primary Reviewer

Writes the most detailed critique and presents the application to the panel first. The primary reviewer summarizes the project's goals, strengths, and weaknesses across all review criteria. This initial presentation sets the tone for the discussion. An enthusiastic primary reviewer can generate momentum that carries through the discussion; a critical primary reviewer creates headwinds that are difficult to overcome.

Secondary Reviewer

Writes an independent critique and presents after the primary reviewer. The secondary reviewer may reinforce the primary's assessment or raise different concerns. When the primary and secondary reviewers agree, their combined view is highly influential. When they disagree, the panel discussion becomes particularly important, as other members weigh in to reconcile the divergent opinions.

Tertiary Reviewer

Also writes an independent critique but provides a briefer presentation, often highlighting points of agreement or disagreement with the other reviewers. The tertiary reviewer can serve as a tiebreaker when the primary and secondary disagree, and may bring a different perspective (for example, methodological expertise that complements the other reviewers' content expertise).

The assigned reviewers draft their critiques independently before the meeting. Each criterion receives a score and written evaluation. These pre-meeting critiques are visible to all panel members before the discussion begins, so the written text shapes how the broader panel approaches the application even before the oral presentation. This is why the quality of your written application matters so much — the critiques are based entirely on the written document, not on oral presentations by the PI (who is not present during review).

What Happens at the Study Section Meeting

Study section meetings span 2-3 days and are conducted either in person (typically in the Bethesda, Maryland area) or virtually via video conference. The meeting follows a structured format designed to ensure thorough, fair, and efficient review.

Pre-Meeting Preparation

Before the meeting, all panel members receive the applications, conflict-of-interest disclosures are managed, and the assigned reviewers post their preliminary scores and written critiques. All members are expected to read at least the Specific Aims of every application and the full text of any application for which they might have expertise or opinions. The preliminary scores from the three assigned reviewers determine which applications will be discussed.

Triage (Streamlining)

Applications whose preliminary scores from the assigned reviewers fall in the bottom half of the pool are "streamlined" — they are not discussed at the meeting. The exact cutoff varies by study section and review round, but typically 40-50% of applications are streamlined. Streamlined applications still receive the three written critiques, which are compiled into a summary statement. They do not receive an impact score or percentile.

Any panel member can "rescue" an application from the streamlined pile by requesting discussion, even if they are not an assigned reviewer. This occasionally happens when a panel member sees merit that the assigned reviewers missed, but it is uncommon. If you are streamlined, it typically means the application needs substantial revision.

The Discussion

For each discussed application, the chairperson calls on the primary reviewer to present. The primary summarizes the project (goals, significance, innovation, approach) and highlights key strengths and weaknesses. The secondary and tertiary reviewers follow with their assessments, noting points of agreement and disagreement. The chairperson then opens the floor to all panel members for additional comments and questions.

The discussion typically lasts 10-20 minutes per application, though controversial or complex applications may receive more time. The chairperson ensures that the discussion stays focused on scientific merit and that all voices are heard. At the end of the discussion, the assigned reviewers may adjust their preliminary scores based on points raised during the discussion. Then all eligible panel members submit their final Overall Impact scores electronically.

What Applicants Should Know About the Meeting Dynamic

• You are not present: NIH review is "closed" — applicants do not attend or present at the study section meeting. Your application must speak for itself.
• Reviewers are time-constrained: With 60-80 applications to discuss over 2-3 days, each application gets limited airtime. Clear, concise writing helps reviewers advocate for your application efficiently.
• The primary reviewer sets the tone: An enthusiastic primary reviewer can pull the panel toward a good score, while a critical primary makes it difficult for others to argue for a high score.
• Scores tend to cluster: Panel members who are not assigned reviewers often score within the range set by the assigned reviewers, unless the discussion raises a point that shifts opinions.
• Summary statements are written after the meeting: The SRO compiles the written critiques and meeting discussion into a summary statement, which is posted to eRA Commons approximately 30 days after the meeting.

Understanding Paylines and Funding Decisions

After study section review and Advisory Council concurrence, funding decisions are made by the individual institutes. The primary tool for these decisions is the payline — a percentile cutoff below which applications are generally funded and above which they generally are not.

How Paylines Are Set

Each institute sets its own payline based on its congressional appropriation, existing commitments (ongoing grants, contracts, intramural research), and strategic priorities. Paylines vary significantly across institutes. In a typical year, paylines range from the 8th percentile (highly competitive) to the 25th percentile (relatively accessible) across different institutes. Some institutes publish their paylines on their websites; others communicate them informally through program officers.

Applications Near the Payline

Applications that fall within a few percentile points above the payline enter a "gray zone" where program officers and institute leadership exercise discretion. Factors that can push a gray-zone application into the funded category include: alignment with institute strategic priorities, portfolio balance (the institute may want to fund research in an underrepresented area), New Investigator or ESI status, and programmatic needs. This is where having an established relationship with your program officer can make a real difference, as they advocate for meritorious applications within their portfolio.

Select Pay and Exception Pay

Some institutes use "select pay" to fund applications beyond the standard payline. Select pay decisions are made by institute directors based on programmatic considerations. Applications that are "select paid" typically scored well (within a few percentile points of the payline) and address a strategic priority. There is no formal application process for select pay — it happens at the institute's discretion, though program officers may advocate for specific applications.

Sample Paylines Across Institutes (Illustrative)

Note: Actual paylines change each fiscal year. Check with your program officer for current numbers.

• NIGMS: ~22nd-25th percentile (historically among the most generous)
• NIAID: ~15th-18th percentile
• NCI: ~12th-15th percentile
• NIMH: ~15th-18th percentile
• NHLBI: ~14th-18th percentile
• NINDS: ~18th-22nd percentile
• ESI advantage: Many institutes add 3-5 percentile points for Early Stage Investigators

How to Choose the Right Study Section for Your Application

Choosing the right study section is one of the most impactful strategic decisions in the application process. An application reviewed by a panel that understands and values the work will score better than the same application reviewed by a panel that lacks the relevant expertise or context.

Research the Options

CSR publishes the roster and description of every standing study section on its website (csr.nih.gov). Each study section has a written description of its scientific scope, and you can review the membership roster to see who currently serves. Look for panels where the members publish in journals you read, use methods similar to yours, and study questions related to your proposal.

Use the CSR Assisted Referral Tool (ART)

CSR provides an online tool that suggests study sections based on your Specific Aims text. While imperfect, it gives a starting point and may identify panels you had not considered. You can also contact the CSR Division Director for the relevant scientific area to discuss options.

Request Assignment in Your Cover Letter

Your cover letter should include both a study section request and an institute assignment request. CSR honors study section requests when the science is a reasonable match. If you do not request a study section, CSR assigns based on its algorithms, which may not always place your application in the most favorable panel. Be specific in your request and briefly explain why the requested panel is appropriate.

Strategic Considerations When Choosing a Panel

• Expertise match: Your reviewers need to understand your methods and appreciate your scientific question. A panel focused on clinical trials may not value basic mechanistic work, and vice versa.
• Review culture: Some panels are known for scoring stringently while others score more generously. Talk to colleagues who have been reviewed by the panels you are considering.
• Member composition: Check the roster for potential advocates — scientists whose work intersects with yours and who would naturally appreciate your contribution.
• Avoid panels where you have competitors: If a direct competitor sits on a panel, they will be conflicted out, but their close collaborators may still be members and could carry implicit biases.

Common Misconceptions About NIH Peer Review

Misconception: "The study section decides whether to fund my grant."

Reality: Study sections assess scientific merit and assign scores. Funding decisions are made by institute staff based on scores, paylines, and programmatic priorities. A study section can give your application an excellent score, but it is the institute that decides whether to fund it.

Misconception: "My application was triaged because the science is bad."

Reality: Triage means your application was not among the top half in a particular review round. With success rates around 20%, even good science gets triaged regularly. Many applications that are ultimately funded were triaged on their first submission. Read the critiques carefully — they often reveal that specific presentation issues, not fundamental scientific problems, led to the triage.

Misconception: "The Overall Impact score is the average of the five criterion scores."

Reality: The Overall Impact score reflects the reviewer's holistic assessment of the application's likelihood of having a sustained, powerful influence on the research field. It is influenced by but not mathematically derived from the criterion scores. A reviewer can assign moderate criterion scores but a strong Overall Impact score if they believe the project, despite some limitations, addresses an important gap in a compelling way.

Misconception: "Reviewers spend days carefully reading every word of my application."

Reality: Assigned reviewers typically spend 2-4 hours per application. Non-assigned members may spend 30 minutes to an hour on applications they review during the meeting. This means clarity, structure, and visual formatting matter enormously. If a reviewer has to hunt for your key points, they will not find them. Write for a busy, expert reader who is evaluating your application alongside 7-9 others.

Misconception: "Resubmissions are treated less favorably than new applications."

Reality: Resubmissions (A1 applications) that thoughtfully address reviewer concerns often score better than the original submission. Reviewers appreciate seeing that the PI engaged seriously with the critiques. However, the A1 is reviewed as a complete application on its own merits — an introduction page explaining changes is helpful, but the research strategy itself must stand on its own.

Related Resources

Understanding peer review is essential for writing competitive applications. Use the resources below to strengthen your overall grant strategy.